Search

Your search keyword '"Liang, Tony"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Liang, Tony" Remove constraint Author: "Liang, Tony"
133 results on '"Liang, Tony"'

Search Results

4. Supplementary Table 1 from Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

5. Supplementary Figure 3 from Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

6. Supplementary Figure 2 from Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

7. Supplementary Figure Legend from Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

8. Supplementary Table 2 from Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

9. Supplementary Figure 4 from Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

10. Supplementary Figure 1 from Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

19. P-220: Use of Carfilzomib regimens in patients with Multiple Myeloma refractory to CD38 antibodies: a subgroup analysis from a prospective observational study

20. Influence of Nose Bluntness on Crossflow Instability.

22. Abstract 1832: Development of a splicing modulator-based ADC payload class with immune stimulatory properties for cancer therapy

28. Safe and Sound (Asleep) : Sleep Pod Safety Perceptions

32. Neutrophil transepithelial migration: regulation at the apical epithelial surface by Fc-mediated events

33. Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation

34. Feedback forum

36. Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasion

38. Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index

39. Abstract 4570: Development of a proteolytically activatable EGFR Probody for cancer therapy.

42. Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

43. Abstract 2725: Preclinical development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent anti-tumor activity

48. Neutrophil Transmigration under Shear Flow Conditions In Vitro Is Junctional Adhesion Molecule-C Independent

49. The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo

50. Vascular Endothelial-Junctional Adhesion Molecule (VE-JAM)/JAM 2 Interacts with T, NK, and Dendritic Cells Through JAM 3

Catalog

Books, media, physical & digital resources